Table 1

Comparative microarrays analysis of the gene expression between strains CSM and EC1118

CategoryaP valueGenes upregulated in strain CSM (fold induction)
A
    Thiamine biosynthetic process1.04e−6THI12 (10.88), THI11 (8.44), THI13 (6.71), THI5 (2.65)
    Aryl alcohol dehydrogenase5.19e−13AAD15 (3.42), AAD10 (2.86), AAD6 (2.30), AAD14 (2.24), AAD4 (2.05), AAD3 (2.04)
    Oxidoreductase activity4.82e−10ERG11 (2.70), ERG5 (2.66), FRE7 (2.28), MET12 (2.22), GTT1 (2.15), COX8 (2.05)
    OthersHPA2 (4.16), RDL1 (3.92), SPG4 (3.55), RIM4 (2.97), YOR348c (2.94), RDL2 (2.82)
B
    Glucose metabolic process4.1e−12ENO2 (4.55), TDH3 (3.65), PFK1 (3.38), ENO1 (2.98), TDH2 (2.91), PGK1 (2.74), TPI1 (2.54)
    Amino acid metabolic process8e−14ADH3 (4.50), ARG4 (4.09), ADH5 (4.06), MET16 (3.86), MET17 (3.71), SER33 (3.37), CYS3 (3.35), CPA1 (3.31), BAT1 (3.04), MET22 (2.92), ARO3 (2.59), MET14 (2.55)
    OthersYIL060w (3.74), YCT1 (3.43), SPT4 (3.00), PMA1 (2.88), YCR023c (2.79), POL4 (2.63), HXT3 (2.62), JLP1 (2.60), ROG3 (2.56), PDR12 (2.54), CYR1 (2.49), HRK1 (2.37)
  • a A, functional categories overrepresented in the genes upregulated by a factor of 2 or more in strain CSM; B, functional categories overrepresented in the genes upregulated by a factor of 2 or more in strain EC1118. The induction level of each gene is shown in parentheses. In both categories, all of the genes upregulated more than 2.5-fold have been included.